Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Share-based Compensation

v3.8.0.1
Note 8 - Share-based Compensation
 6 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note
8.
Share-based Compensation:
 
During the
 
six
months
 ended
December 31, 2017
and
2016,
the Company granted 
1.0
million and
1.1
million stock options at weighted average grant prices of
$118.97
and
$107.4
0
and weighted average fair values of
$21
.58
and
$18.13,
respectively. During the
six
months ended
December 31, 2017
and
2016,
the Company granted 
35,674
and
64
,931
restricted stock units at weighted average fair values of
$125.02
and
$109.36,
respectively. During the
six
months ended
December 31, 2017
and
2016,
the Company granted
20,106
and
23,965
shares of restricted at grant date fair values of
$125.05
and
$104.94,
respectively.
 
Stock options
for 
70
,069
and
23,145
shares of common stock with total intrinsic values of
$2
.8
million and
$1.0
million were exercised during the
six
months ended
December 31, 2017
and
2016,
respectively.
 
Stock-based
compensation expense of
$5
.0
million and
$4.1
million was included in selling, general and administrative expenses for the quarter ended
December 31, 2017
and
2016,
respectively. Stock-based compensation expense of
$8.8
million and
$7.2
million was included in selling, general and administrative expenses for the
six
months ended
December 31, 2017
and
2016,
respectively. As of
December 31, 2017,
there was
$40
.2
million of unrecognized compensation cost related to non-vested stock options, non-vested restricted stock units and non-vested restricted stock. The weighted average period over which the compensation cost is expected to be recognized is 
2.5
years.